Current and historical daily PE Ratio for Medlive Technology Co Ltd (
) from 2021 to Jun 04 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medlive Technology stock (HKSE:02192) PE ratio as of Jun 04 2024 is 21.64.
More Details
Medlive Technology Co Ltd (HKSE:02192) PE Ratio (TTM) Chart
Medlive Technology Co Ltd (HKSE:02192) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 713
- 1
- 2
- 3
- 4
- 5
- 6
- 8
| Medlive Technology PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | 21.6 | 2024-03-27 | 20.8 |
| 2024-06-04 | 21.6 | 2024-03-26 | 20.3 |
| 2024-06-03 | 20.9 | 2024-03-25 | 20.9 |
| 2024-05-31 | 21.1 | 2024-03-22 | 20.8 |
| 2024-05-30 | 21.2 | 2024-03-21 | 21.4 |
| 2024-05-29 | 21.2 | 2024-03-20 | 20.7 |
| 2024-05-28 | 21.5 | 2024-03-19 | 20.8 |
| 2024-05-27 | 21.3 | 2024-03-18 | 20.8 |
| 2024-05-24 | 21.2 | 2024-03-15 | 20.8 |
| 2024-05-23 | 21.6 | 2024-03-14 | 20.8 |
| 2024-05-22 | 22.9 | 2024-03-13 | 20.8 |
| 2024-05-21 | 22.8 | 2024-03-12 | 21.6 |
| 2024-05-20 | 23.9 | 2024-03-11 | 20.6 |
| 2024-05-17 | 24.7 | 2024-03-08 | 20.0 |
| 2024-05-16 | 23.3 | 2024-03-07 | 20.2 |
| 2024-05-14 | 23.3 | 2024-03-06 | 20.4 |
| 2024-05-13 | 23.1 | 2024-03-05 | 20.3 |
| 2024-05-10 | 23.5 | 2024-03-04 | 20.8 |
| 2024-05-09 | 23.7 | 2024-03-01 | 20.3 |
| 2024-05-08 | 23.6 | 2024-02-29 | 20.6 |
| 2024-05-07 | 24.4 | 2024-02-28 | 20.3 |
| 2024-05-06 | 24.2 | 2024-02-27 | 21.1 |
| 2024-05-03 | 24.2 | 2024-02-26 | 20.3 |
| 2024-05-02 | 24.3 | 2024-02-23 | 20.6 |
| 2024-04-30 | 23.1 | 2024-02-22 | 20.1 |
| 2024-04-29 | 22.7 | 2024-02-21 | 19.4 |
| 2024-04-26 | 22.6 | 2024-02-20 | 18.8 |
| 2024-04-25 | 23.0 | 2024-02-19 | 18.6 |
| 2024-04-24 | 22.8 | 2024-02-16 | 17.9 |
| 2024-04-23 | 21.9 | 2024-02-15 | 16.9 |
| 2024-04-22 | 20.7 | 2024-02-14 | 16.9 |
| 2024-04-19 | 20.3 | 2024-02-09 | 17.2 |
| 2024-04-18 | 20.9 | 2024-02-08 | 17.5 |
| 2024-04-17 | 20.4 | 2024-02-07 | 17.2 |
| 2024-04-16 | 20.4 | 2024-02-06 | 17.3 |
| 2024-04-15 | 21.3 | 2024-02-05 | 16.6 |
| 2024-04-12 | 22.2 | 2024-02-02 | 16.8 |
| 2024-04-11 | 22.2 | 2024-02-01 | 16.8 |
| 2024-04-10 | 23.1 | 2024-01-31 | 17.2 |
| 2024-04-09 | 23.1 | 2024-01-30 | 17.3 |
| 2024-04-08 | 22.6 | 2024-01-29 | 17.2 |
| 2024-04-05 | 21.4 | 2024-01-26 | 18.0 |
| 2024-04-03 | 21.3 | 2024-01-25 | 18.1 |
| 2024-04-02 | 21.5 | 2024-01-24 | 18.1 |
| 2024-03-28 | 21.0 | 2024-01-23 | 17.7 |
Medlive Technology Co Ltd (HKSE:02192) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Medlive Technology Co Ltd
ISIN : KYG5961B1041
Compare
Compare
Traded in other countries / regions
02192.Hong Kong IPO Date
2021-07-15Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers